Verteporfin photodynamic therapy of six eyes with retinal capillary haemangioma

Acta Ophthalmologica

Volumn 88, Issue 8, 2010, Pages

  Sachdeva, Reecha ^a   Dadgostar, Hajir ^a   Kaiser, Peter K ^a   Sears, Jonathan E ^a   Singh, Arun D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

photodynamic therapy; retinal capillary haemantioma; verteporfin; von Hippel Lindau disease

Indexed keywords

BEVACIZUMAB; VERTEPORFIN;

ADOLESCENT; ADULT; ARTICLE; CAPILLARY HEMANGIOMA; CASE STUDY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE EXACERBATION; DRUG EFFICACY; EPIRETINAL MEMBRANE; EYE FUNDUS; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; LASER COAGULATION; LIGHT EXPOSURE; MALE; MEDICAL RECORD REVIEW; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA BLOOD VESSEL OCCLUSION; RETINAL CAPILLARY HEMANGIOMA; RETREATMENT; RETROSPECTIVE STUDY; SUBRETINAL FLUID; TREATMENT RESPONSE; TUMOR REGRESSION; VISUAL ACUITY; VISUAL DISORDER; VITREOUS HEMORRHAGE; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; CHILD; FEMALE; HEMANGIOMA, CAPILLARY; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINAL NEOPLASMS; RETREATMENT; RETROSPECTIVE STUDIES; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 78649847470     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02008.x     Document Type: Article

References (39)

1. Aaberg TM Jr, Aaberg TM Sr, Martin DF, et al. (2005): Three cases of large retinal capillary haemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol 123: 328-332.
2. Allison BA, Waterfield E, Richter AM, &, Levy JG, (1991): The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol 54: 709-715.
3. Annesley WH Jr, Leonard BC, Shields JA, &, Tasman WS, (1977): Fifteen-year review of treated cases of retinal angiomatosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83: 446-453.
4. Atebara NH, (2002): Retinal capillary hemangioma treated with verteporfin photodynamic therapy. Am J Ophthalmol 134: 788-790.
5. Bakri SJ, Sears JE, &, Singh AD, (2005): Transient closure of a retinal capillary hemangioma with verteporfin photodynamic therapy. Retina 25: 1103-1104.
6. Barbazetto I, &, Schmidt-Erfurth U, (2000): Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol 238: 214-221.
7. Barbezetto IA, &, Smith RT, (2003): Vasoproliferative tumor of the retina treated with PDT. Retina 23: 565-567.
8. Blodi CF, Russell SR, &, Pulido JS, (1990): Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology 97: 791-797.
9. Cardoso RD, &, Brockhurst RJ, (1976): Perforating diathermy coagulation for retinal angiomas. Arch Ophthalmol 94: 1702-1715.
10. Chan CC, Collins AB, &, Chew EY, (2007): Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review. Retina 27: 1-7.
11. Chew EY, (2005): Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans Am Ophthalmol Soc 103: 495-511.
12. Cruess AF, Zlateva G, Pleil AM, &, Wirostko B, (2009): Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties. Acta Ophthalmol 87: 2.
13. Fogelman AM, Berliner JA, Van Lenten BJ, Navab M, &, Territo M, (1988): Lipoprotein receptors and endothelial cells. Semin Thromb Hemost 14: 206-209.
14. Gass JD, &, Braunstein R, (1980): Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head. Arch Ophthalmol 98: 1790-1797.
15. Gaynes BI, &, Fiscella RG, (2004): Safety of verteporfin for treatment of subfoveal choroidal neovascular membranes associated with age-related macular degeneration. Expert Opin Drug Saf 3: 345-361.
16. Golshevsky JR, &, O'Day J, (2005): Photodynamic therapy in the management of juxtapapillary capillary haemangiomas. Clin Experiment Ophthalmol 33: 509-512.
17. Johnson MW, Flynn HW Jr, &, Gass JDM, (1992): Pars plana vitrectomy and direct diathermy for complications of multiple retinal angiomas. Ophthalmic Surg 23: 47-50.
18. Lane CM, Turner G, &, Gregor ZJ, (1989): Laser treatment of retinal angiomatosis. Eye 3: 1.
19. Maar N, Pemp B, Kircher K, et al. (2009): Ocular haemodynamic changes after single treatment with photodynamic therapy assessed with non-invasive techniques. Acta Ophthalmol 87: 6.
20. McCabe CM, Flynn HW Jr, &, Shields CL, (2000): Juxtapapillary capillary hemangiomas: clinical features and visual acuity outcomes. Ophthalmology 107: 2240-2248.
21. Mennel S, Meyer CH, &, Callizo J, (2010): Combined intravitreal anti-vascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma. Acta Ophthalmol 88: 610-613.
22. Obeso J, Weber J, &, Auerbach R, (1990): A hemangioendothelioma- derived cell line: its use as a model for the study of endothelial cell biology. Lab Invest 63: 259-269.
23. Oosterhuis JA, &, Rubinstein K, (1972): Haemangioma at the optic disc. Ophthalmologica 164: 362-374.
24. Rodriquez-Coleman H, Spaide RF, &, Yannuzzi LA, (2002): Treatment of angiomatous lesions of the retina with photodynamic therapy. Retina 22: 228-232.
25. Schmidt-Erfurth U, Hasan T, &, Gragoudas E, (1994): Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101: 1953-1961.
26. Schmidt-Erfurth U, Hasan T, &, Schomacker K, (1995): In vivo-uptake of liposomal benzoporphyrin derivative and photothrombosis in experimental corneal neovascularization. Lasers Surg Med 17: 178-188.
27. Schmidt-Erfurth U, Kusserow C, Barbazetto IA, &, Laqua H, (2002): Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 109: 1256-1266.
28. Shields JA, &, Shields CL, (1992): Vascular tumors of the retina and optic disc. Intraocular tumors: a Text and Atlas. Philadelphia: WB Saunders.
29. Singh AD, Shields CL, &, Shields JA, (2001a): Von Hippel-Lindau disease. Surv Ophthalmol 46: 117-142.
30. Singh AD, Shields JA, &, Shields CL, (2001b): Solitary retinal capillary hemangioma: hereditary (von Hippel-Lindau disease) or nonhereditary? Arch Ophthalmol 119: 232-234.
31. Singh AD, Nouri M, &, Shields CL, (2002): Treatment of retinal capillary hemangioma. Ophthalmology 109: 1799-1806.
32. Singh AD, Kaiser PK, &, Sears JE, (2005): Choroidal hemangioma. Ophthalmol Clin North Am 18: 151-161.
33. Singh AD, Rundle PA, &, Rennie I, (2007): Retinal vascular tumors. In:, Singh AD, ((ed.)) Clinical ophthalmic oncology. Philadelphia: Elsevier-Saunders 341-343.
34. Suh SC, Jin SY, Bae SH, et al. (2007): Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide. Korean J Ophthalmol 21: 178-184.
35. Szabo A, Gehl Z, &, Seres A, (2005): Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters. Acta Ophthalmol Scand 83: 512-513.
36. Toda K, Tsujioka K, &, Maruguchi Y, (1990): Establishment and characterization of tumorigenic murine vascular endothelial cell line. Cancer Res 50: 5526-5530.
37. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group (1999): Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 117: 1329-1345.
38. Welch RB, (1970): Von Hippel-Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy. Trans Am Ophthalmol Soc 68: 367-424.
39. Ziemssen F, Voelker M, Inhoffen W, et al. (2007): Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy. Eye 21: 1125-1126.